| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.281.1.67 |
| P698 | PubMed publication ID | 9892453 |
| P2093 | author name string | M J Struelens | |
| H Goossens | |||
| J A Garcia-Rodriguez | |||
| H Hanberger | |||
| L E Nilsson | |||
| M Gobernado | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intensive care unit | Q5094647 |
| P304 | page(s) | 67-71 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups | |
| P478 | volume | 281 |
| Q36950581 | Acinetobacter infections: a growing threat for critically ill patients |
| Q34108244 | Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns |
| Q33692732 | Antibiotic Resistance Pattern and Evaluation of Metallo-Beta Lactamase Genes Including bla- IMP and bla- VIM Types in Pseudomonas aeruginosa Isolated from Patients in Tehran Hospitals |
| Q49033667 | Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units |
| Q44016762 | Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patien |
| Q54046322 | Antibiotic use and bacterial resistance |
| Q34227358 | Antimicrobial resistance in the chronically critically ill patient |
| Q43903024 | Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. |
| Q31974278 | Antipseudomonal antibiotics. |
| Q83278107 | Automatic detection of patients with nosocomial infection by a computer-based surveillance system: a validation study in a general hospital |
| Q24813204 | Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit |
| Q34621459 | Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections |
| Q57780056 | Comment améliorer la qualité de l’antibiothérapie dans les établissements de soins ? |
| Q25256737 | Comparative genomics of multidrug resistance in Acinetobacter baumannii |
| Q41878559 | Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (active) reduced state |
| Q51664905 | Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia. |
| Q37482006 | Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae. |
| Q33972291 | Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase |
| Q35840834 | Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. |
| Q33593668 | Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec |
| Q24798403 | Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002) |
| Q43902160 | Evolution of susceptibility of aerobic gram-negative aerobic bacilli to quinolones and fluoroquinolones in a university hospital (1992-2000) |
| Q33736461 | Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin |
| Q37189488 | Extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Malian orphanage |
| Q24534999 | Extended-spectrum beta-lactamases: a clinical update |
| Q35558473 | Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control |
| Q44054801 | Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). |
| Q44786348 | High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility |
| Q73615041 | High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units |
| Q35685608 | Hospital-acquired pneumonia: diagnostic strategies: lessons from clinical trials |
| Q33675546 | Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review |
| Q44976445 | In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa |
| Q39474230 | In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia |
| Q41954040 | Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU). |
| Q39740679 | Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories |
| Q57215814 | Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea |
| Q34130045 | Monotherapy versus combination therapy for bacterial infections. |
| Q33711902 | Multidrug resistant Acinetobacter |
| Q44668939 | Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India |
| Q64283677 | Multidrug-resistant septicemia in neonates: A study from a teaching hospital of Northern India |
| Q37624421 | National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. |
| Q45141635 | Occurrence of endemic plasmids causing beta-lactam resistance in Enterobacteriaceae in children's university hospital in Munich |
| Q24795736 | Opinion: the clinical use of selective digestive decontamination |
| Q24796204 | Optimizing antibiotic therapy in the intensive care unit setting |
| Q43942786 | Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study |
| Q33805410 | Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. |
| Q36845404 | Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California |
| Q34458678 | Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections |
| Q33649676 | Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections |
| Q35646207 | Prevalence of bla (CTX M) extended spectrum beta lactamase gene in enterobacteriaceae from critical care patients |
| Q35595002 | Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial |
| Q36735014 | Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial |
| Q53924099 | Relationship between nosocomial Acinetobacter species occurring in two geographical areas (Greece and the UK). |
| Q36364145 | Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli. |
| Q37222605 | Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides |
| Q34881867 | Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. |
| Q39462477 | Simple and inexpensive but highly discriminating method for computer-assisted DNA fingerprinting of Pseudomonas aeruginosa |
| Q60531007 | Spectrum and transferability of β-lactam resistance in hospital strains of Enterobacter isolated in Bratislava and Innsbruck |
| Q57804879 | Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections |
| Q36575116 | The Klebsiella pneumoniae O antigen contributes to bacteremia and lethality during murine pneumonia |
| Q44373855 | The effects of supraphysiological doses of corticosteroids in hypotensive liver failure |
| Q45743027 | The impact of Acinetobacter baumannii infections on outcome in trauma patients: A matched cohort study |
| Q73864773 | The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains |
| Q33388227 | The major surface-associated saccharides of Klebsiella pneumoniae contribute to host cell association |
| Q35595833 | The rising problem of antimicrobial resistance in the intensive care unit |
| Q42287921 | Therapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center |
| Q61446584 | Therapeutic guidelines for Pseudomonas aeruginosa infections |
| Q36501497 | Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey |
| Q33943527 | Toward multinational antimicrobial resistance surveillance systems in Europe |
| Q40405905 | Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections |
| Q34020982 | Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial |
| Q36744796 | Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group |
| Q79788312 | [Control scale of antibiotic prescriptions in intensive care] |
| Q54046326 | [Regulation of the use of antibiotics: objectives, means and perspectives] |
| Q53990602 | [Spread of Enterobacteriaceae producing broad-spectrum beta-lactamase and the development of their incidence over a 16-month period in a university hospital center] |
Search more.